Literature DB >> 22465315

Risk factors for peripheral arterial disease among patients with chronic kidney disease.

Jing Chen1, Emile R Mohler, Dawei Xie, Michael G Shlipak, Raymond R Townsend, Lawrence J Appel, Dominic S Raj, Akinlolu O Ojo, Martin J Schreiber, Louise F Strauss, Xiaoming Zhang, Xin Wang, Jiang He, L Lee Hamm.   

Abstract

Patients with chronic kidney disease (CKD) have an increased risk for developing peripheral arterial disease (PAD). The aim of this study was to examine the cross-sectional association between novel risk factors and prevalent PAD in patients with CKD. A total of 3,758 patients with estimated glomerular filtration rates of 20 to 70 ml/min/1.73 m(2) who participated in the Chronic Renal Insufficiency Cohort (CRIC) study were included in the present analysis. PAD was defined as an ankle-brachial index <0.9 or a history of arm or leg revascularization. After adjustment for age, gender, race, cigarette smoking, physical activity, history of hypertension and diabetes, pulse pressure, high-density lipoprotein cholesterol, estimated glomerular filtration rate, and CRIC clinical sites, several novel risk factors were significantly associated with PAD. For example, odds ratios for a 1-SD higher level of risk factors were 1.18 (95% confidence interval [CI] 1.08 to 1.29) for log-transformed high-sensitivity C-reactive protein, 1.18 (95% CI 1.08 to 1.29) for white blood cell count, 1.15 (95% CI 1.05 to 1.25) for fibrinogen, 1.13 (95% CI 1.03 to 1.24) for uric acid, 1.14 (95% CI 1.02 to 1.26) for glycosylated hemoglobin, 1.11 (95% CI 1.00 to 1.23) for log-transformed homeostasis model assessment of insulin resistance, and 1.35 (95% CI 1.18 to 1.55) for cystatin C. In conclusion, these data indicate that inflammation, prothrombotic state, oxidative stress, insulin resistance, and cystatin C were associated with an increased prevalence of PAD in patients with CKD. Further studies are warranted to examine the causal effect of these risk factors on PAD in patients with CKD.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465315      PMCID: PMC3586781          DOI: 10.1016/j.amjcard.2012.02.061

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

1.  When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid.

Authors:  M Bagnati; C Perugini; C Cau; R Bordone; E Albano; G Bellomo
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

Review 3.  Consensus Development Conference on Insulin Resistance. 5-6 November 1997. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  1998-02       Impact factor: 19.112

4.  Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.

Authors:  Duk-Hee Kang; Sung-Kwang Park; In-Kyu Lee; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2005-10-26       Impact factor: 10.121

5.  Relationship between HbA1c level and peripheral arterial disease.

Authors:  Paul Muntner; Rachel P Wildman; Kristi Reynolds; Karen B Desalvo; Jing Chen; Vivian Fonseca
Journal:  Diabetes Care       Date:  2005-08       Impact factor: 19.112

6.  Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

Authors:  F J Nieto; C Iribarren; M D Gross; G W Comstock; R G Cutler
Journal:  Atherosclerosis       Date:  2000-01       Impact factor: 5.162

7.  Human blood pressure determination by sphygmomanometry.

Authors:  D Perloff; C Grim; J Flack; E D Frohlich; M Hill; M McDonald; B Z Morgenstern
Journal:  Circulation       Date:  1993-11       Impact factor: 29.690

8.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

9.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

Review 10.  Emerging risk factors for atherosclerotic vascular disease: a critical review of the evidence.

Authors:  Daniel G Hackam; Sonia S Anand
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

View more
  24 in total

1.  Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh; Hisatomi Arima; Johan Ärnlöv; Massimo Cirillo; Natalie Ebert; Jade S Hiramoto; Heejin Kimm; Michael G Shlipak; Frank L J Visseren; Ron T Gansevoort; Csaba P Kovesdy; Varda Shalev; Mark Woodward; Florian Kronenberg
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-14       Impact factor: 32.069

2.  Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia.

Authors:  Abhisekh Mohapatra; Aureline Boitet; Othman Malak; Jon C Henry; Efthimios D Avgerinos; Michel S Makaroun; Eric S Hager; Rabih A Chaer
Journal:  J Vasc Surg       Date:  2018-06-28       Impact factor: 4.268

3.  Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.

Authors:  Jair Munoz Mendoza; Tamara Isakova; Xuan Cai; Liz Y Bayes; Christian Faul; Julia J Scialla; James P Lash; Jing Chen; Jiang He; Sankar Navaneethan; Lavinia Negrea; Sylvia E Rosas; Matthias Kretzler; Lisa Nessel; Dawei Xie; Amanda Hyre Anderson; Dominic S Raj; Myles Wolf
Journal:  Kidney Int       Date:  2016-12-22       Impact factor: 10.612

4.  Heel Wounds Predict Mortality but Not Amputation after Infrapopliteal Revascularization.

Authors:  Abhisekh Mohapatra; Jon C Henry; Efthimios D Avgerinos; Rabih A Chaer; Steven A Leers; Aureline Boitet; Michael J Singh; Eric S Hager
Journal:  Ann Vasc Surg       Date:  2018-03-06       Impact factor: 1.466

5.  Traditional and non-traditional risk factors for incident peripheral arterial disease among patients with chronic kidney disease.

Authors:  Jing Chen; Emile R Mohler; Dawei Xie; Michael Shlipak; Raymond R Townsend; Lawrence J Appel; Akinlolu Ojo; Martin Schreiber; Lisa Nessel; Xiaoming Zhang; Dominic Raj; Louise Strauss; Claudia M Lora; Mahboob Rahman; L Lee Hamm; Jiang He
Journal:  Nephrol Dial Transplant       Date:  2015-12-18       Impact factor: 5.992

Review 6.  Peripheral artery disease and chronic kidney disease: clinical synergy to improve outcomes.

Authors:  Pranav S Garimella; Alan T Hirsch
Journal:  Adv Chronic Kidney Dis       Date:  2014-10-24       Impact factor: 3.620

Review 7.  Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state.

Authors:  Cristiana Catena; GianLuca Colussi; Francesca Nait; Francesca Pezzutto; Flavia Martinis; Leonardo A Sechi
Journal:  World J Nephrol       Date:  2015-07-06

8.  Elevated Neutrophil-to-Lymphocyte Ratio Predicts Intermediate-Term Outcomes in Patients Who Have Advanced Chronic Kidney Disease with Peripheral Artery Disease Receiving Percutaneous Transluminal Angioplasty.

Authors:  I-Chih Chen; Chao-Chin Yu; Yi-Hsuan Wu; Ting-Hsing Chao
Journal:  Acta Cardiol Sin       Date:  2016-09       Impact factor: 2.672

9.  Bypass versus endovascular intervention for healing ischemic foot wounds secondary to tibial arterial disease.

Authors:  Abhisekh Mohapatra; Jon C Henry; Efthimios D Avgerinos; Aureline Boitet; Rabih A Chaer; Michel S Makaroun; Steven A Leers; Eric S Hager
Journal:  J Vasc Surg       Date:  2018-01-11       Impact factor: 4.268

10.  Clinical outcomes among patients with chronic kidney disease hospitalized with diabetic foot disorders: A nationwide retrospective study.

Authors:  Michael Salim
Journal:  Endocrinol Diabetes Metab       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.